iBio, Inc.

US$0.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IBIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (55.73%)
Div yield —
ROE (65.70%)
Biotechnology
Beta (5Y) 1.48
PE TTM —
TSR TTM (53.84%)
Mkt cap US$47.50M
ROIC (35.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.718
(2.72%)
(81.95%)
Hold 7|7|4|5|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.01
0.02
13.22%
7.24%
(0.42%)
10.02%
Revenue$M
2.210
2.294
2.282
2.293
4.76%
3.08%
0.65%
4.21%
Peers (US$47.50M)
Cap (US$)
PE
46.60M
—
46.32M
—
Capital
TTM
5Y
10Y
Leveragex
0.354
(0.213)
(0.186)
EBIT/Intx
0.437
0.230
0.200
Own earn%
38.52
30.16
22.66
Sh yield%
12.35
21.72
22.81
Owners
Insiders/Inst%
2.33
49.46
Short interest%
0.73
SBC / revenue%
2.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–20
$1 testx
0.0
Incr. ROIC%
15